Vitrolife AB

Notice of Annual General Meeting of Vitrolife AB (publ)

The Annual General Meeting of Vitrolife AB (publ) will take place on Monday April 29, 2013, at 5 p.m. in the company’s premises at Gustaf Werners gata 2 in Gothenburg. Notice of attendance at the Annual General Meeting shall be given no later than Tuesday, April 23, 2013, at 12 noon.

Vitrolife’s share capital and number of shares on November 30, 2012

As per November 30, 2012, the total number of shares in Vitrolife AB (publ) amounts to 19,830,936, of which Vitrolife itself holds 0 shares. The share capital amounts to SEK 20,227,554.74.

Election committee for Vitrolife AB (publ)

The following people have been appointed as members of Vitrolife’s election committee for the Annual General Meeting in 2013:

Vitrolife preparing distribution of the transplantation business

Vitrolife AB (publ) is today publishing the decision of the Board to begin preparations for a spin-off of the transplantation business, which today is run in the subsidiary Xvivo Perfusion AB. The spin-off will take place through distribution of the shares in the subsidiary in accordance with “Lex Asea”. It is intended that the shares in Xvivo Perfusion AB will be listed on NASDAQ OMX First North in connection with the distribution.

Election committee for Vitrolife AB (publ)

The following people have been appointed as members of Vitrolife’s election committee for the Annual General Meeting in 2012: Henrik Blomquist, representing Bure Equity AB Johan Ståhl, representing Lannebo Fonder Martin Lewin, representing Eccenovo AB Patrik Tigerschiöld, Chairman of the Board
Syndicate content